| Lytix Biopharma AS. (9/12/19). "Press Release: Lytix Biopharma AS Appoints Øystein Rekdal as the new CEO". |
2019-09-12 |
| Biocrates Life Sciences AG. (9/12/19). "Press Release: Repositioning of Biocrates – Management Change and New Round of Financing". Innsbruck. |
2019-09-12 |
| Genenta Science S.r.l.. (9/11/19). "Press Release: Genenta Science Announces 13.2 Million in a New Round of Financing, Hits a Total above 30 Million since Inception. Two Clinical Trials Ongoing.". Milano & New York, NY. |
2019-09-11 |
| Genedata AG. (9/11/19). "Press Release: Orion Pharmaceuticals Implements Genedata Biologics to Support New Large-Molecule R&D Initiative". Basel. |
2019-09-11 |
| UK Biobank. (9/11/19). "Press Release: UK Biobank Leads the Way in Genetics Research to Tackle Chronic Diseases". |
2019-09-11 |
| Max Planck Society. (9/11/19). "Press Release: Max Planck Society Grants License for New Drug Candidates". |
2019-09-11 |
| Avalon Ventures. (9/11/19). "Press Release: Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK". San Diego, CA. |
2019-09-11 |
| o2h Discovery. (9/11/19). "Press Release: Cedilla Therapeutics and o2h Discovery Are Pleased to Announce Multi FTE Expansion to Their Synthetic Chemistry Collaboration". Cambridge & Cambridge, MA. |
2019-09-11 |
| Immunexpress, Inc.. (9/11/19). "Press Release: Immunexpress Appoints Jane Papadaki Markley as VP of Market Development and Commercial Operations". Seattle, WA. |
2019-09-11 |
| Domain Therapeutics S.A.. (9/11/19). "Press Release: Domain Therapeutics Invests in Ermium Therapeutics to Develop First-in-class CXCR4 Candidate for Autoimmune Diseases". Strasbourg. |
2019-09-11 |
| Kiadis Pharma N.V.. (9/10/19). "Press Release: Kiadis Pharma Announces Results for the Six Months Ended June 30, 2019". Amsterdam. |
2019-09-10 |
| ProBioGen AG. (9/10/19). "Press Release: ProBioGen Licenses GlymaxX Technology to Bayer". Berlin. |
2019-09-10 |
| Keranova S.A.. (9/10/19). "Press Release: Keranova Raises €24m in Second Round of Financing". Saint-Etienne & Lyon. |
2019-09-10 |
| Grünenthal GmbH. (9/10/19). "Press Release: Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain". Aachen & Melbourne. |
2019-09-10 |
| Pharvaris B.V.. (9/10/19). "Press Release: Pharvaris Announces $66 Million Series B Financing to Advance the Clinical Development of an Oral Therapy for Hereditary Angioedema". Leiden. |
2019-09-10 |
| Abionyx Pharma S.A.. (9/9/19). "Press Release: Cyrille Tupin Appointed CEO". Toulouse & Lakeland, US. |
2019-09-09 |
| Cell Mogrify Ltd.. (9/9/19). "Press Release: Mogrify Appoints Dr. Jane Osbourn, OBE as Chair". Cambridge. |
2019-09-09 |
| Lightcast Discovery Ltd.. (9/9/19). "Press Release: Lightcast Discovery Raises £1.3m in Seed Financing to Expand Pilot Studies". Cambridge. |
2019-09-09 |
| BioAscent Discovery Ltd.. (9/9/19). "Press Release: BioAscent Expands into US Market, Appoints Julian Abery to Spearhead Growth". Newhouse. |
2019-09-09 |
| 4BIO Capital (4BIO Ventures Management Ltd.). (9/9/19). "Press Release: 4BIO Capital Raises $50 million in First Close of New Advanced Therapies Fund". London & Boston, MA. |
2019-09-09 |
| Genmab A/S. (9/9/19). "Press Release: Genmab and Tempus Enter into Strategic Collaboration Agreement". Copenhagen. |
2019-09-09 |
| Crain Communications Inc.. (9/6/19). "Press Release: Crain Communications Inc Acquires Online News Organization GenomeWeb". Detroit, MI. |
2019-09-06 |
| Novartis AG. (9/6/19). "Press Release: Novartis Investigational Lung Cancer Therapy Capmatinib (INC280) Granted FDA Breakthrough Therapy Designation for Patients with MET-mutated Advanced Non-small Cell Lung Cancer". Basel. |
2019-09-06 |
| ADC Therapeutics S.A.. (9/6/19). "Press Release: ADC Therapeutics Files Registration Statement for Proposed Initial Public Offering". Lausanne. |
2019-09-06 |
| Owlstone Medical Ltd.. (9/5/19). "Press Release: Owlstone Medical Announces Advancements in Breath Biopsy Platform Including Launch of Next Generation ReCIVA Breath Sampler and CASPER Portable Air Supply". Cambridge. |
2019-09-05 |
| TreeFrog Therapeutics S.A.S.. (9/5/19). "Press Release: TreeFrog Therapeutics Receives Additional €3m Non-dilutive Funding". Bordeaux. |
2019-09-05 |
| Devicare S.L.. (9/5/19). "Press Release: The PREVENTLIT Study Shows that Lit-Control Reduces new Episodes of Renal Lithiasis in Patients". Cerdanyola del Vallès. |
2019-09-05 |
| Sigrid Therapeutics AB. (9/5/19). "Press Release: Stockholm-based Technology Startup Sigrid Therapeutics, Developing SiPore15 – a Breakthrough Device to Lower Blood Sugar Levels, Closes Oversubscribed Round of $1.6m, Bringing Total Pre-launch Funding to |
2019-09-05 |
| iStar Medical S.A.. (9/5/19). "Press Release: iStar Medical Announces EUR 40m Series C Financing". Wavre. |
2019-09-05 |
| Evonik Industries AG. (9/5/19). "Press Release: Evonik Invests in Chinese 3D-printing Start-up Making Medical Implants". Essen & Shanghai. |
2019-09-05 |
| Abionic S.A.. (9/5/19). "Press Release: Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests". Lausanne. |
2019-09-05 |
| Uniqure N.V.. (9/5/19). "Press Release: Uniqure Announces Pricing of its Public Offering". Lexington, MA & Amsterdam. |
2019-09-05 |
| Theragnostics Ltd.. (9/5/19). "Press Release: Theragnostics Signs Agreement with AstraZeneca". London. |
2019-09-05 |
| Modag GmbH. (9/4/19). "Press Release: Modag Appoints Dr. Johannes Levin as Chief Medical Officer". Wendelsheim. |
2019-09-04 |
| Fulcrum Therapeutics, Inc.. (9/4/19). "Press Release: Fulcrum Therapeutics Appoints Pamela Strode, Seasoned Industry Executive, to Lead Regulatory Affairs Team". Cambridge, MA. |
2019-09-04 |
| Boehringer Ingelheim. (9/4/19). "Press Release: Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound". Ingelheim & Mumbai. |
2019-09-04 |
| Uniqure N.V.. (9/4/19). "Press Release: Uniqure Announces Proposed Public Offering". Lexington, MA & Amsterdam. |
2019-09-04 |
| Curetis N.V.. (9/4/19). "Press Release: Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses". Gaithersburg, MD, Amsterdam & Holzgerlingen. |
2019-09-04 |
| AC Immune S.A.. (9/4/19). "Press Release: AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging Agent". Lausanne. |
2019-09-04 |
| BioNTech SE. (9/4/19). "Press Release: BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs". Mainz. |
2019-09-04 |
| Roche. (9/3/19). "Press Release: Roche and Spark Therapeutics, Inc. Announce Extension of Tender Offer for Shares of Spark Therapeutics, Inc.". Basel. |
2019-09-03 |
| Evonik Industries AG. (9/3/19). "Press Release: Evonik Acquires a Surface Modification Technology Platform from Interface Biologics to Further Expand Its Medical Device Capabilities". |
2019-09-03 |
| Agilent Technologies Inc.. (9/3/19). "Press Release: Agilent Collaborates on Groundbreaking Study of Performance-Enhancing Spinach Extract". Santa Clara, CA. |
2019-09-03 |
| Grünenthal GmbH. (9/3/19). "Press Release: Grünenthal and UniQuest Partner to Develop Novel Drug Candidates for Chronic Neuropathic Pain". Aachen & Brisbane. |
2019-09-03 |
| Boehringer Ingelheim. (9/3/19). "Press Release: Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/Glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes". Ingelheim & Copenhagen. |
2019-09-03 |
| Novartis AG. (9/3/19). "Press Release: Sandoz Announces Global Deal to Commercialize Proposed Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine". Holzkirchen. |
2019-09-03 |
| Achilles Therapeutics. (9/3/19). "Press Release: Achilles Therapeutics Raises £100 Million in Oversubscribed Series B Financing". Stevenage. |
2019-09-03 |
| Inotrem S.A.. (9/3/19). "Press Release: Inotrem Announces Fast Track Designation Granted by U.S. FDA to Nangibotide Development Program for the Treatment of Septic Shock". Paris. |
2019-09-03 |
| Uniqure N.V.. (9/3/19). "Press Release: Uniqure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia B". Lexington, MA & Amsterdam. |
2019-09-03 |
| RhoVac AB. (9/2/19). "Press Release: RhoVac Optimizes the Structure of the Management Team and Appoints Anders Månsson as New CEO". |
2019-09-02 |
| Bruker Corporation. (9/2/19). "Press Release: Bruker Launches Highest Resolution Large-Format Bio-AFM System". Münster. |
2019-09-02 |
| Orbit Discovery Ltd.. (8/30/19). "Press Release: Mario Polywka Joins Orbit Discovery’s Board of Directors". Oxford. |
2019-08-30 |
| Novartis AG. (8/30/19). "Press Release: Novartis Ofatumumab Demonstrates Superiority versus Aubagio in Two Head-to-head Phase III Multiple Sclerosis Studies". Basel. |
2019-08-30 |
| Lunaphore Technologies S.A.. (8/30/19). "Press Release: Lunaphore Appoints Joseph Bernardo as New Chairman of the Board". Lausanne. |
2019-08-30 |
| Tecan Group Ltd.. (8/30/19). "Press Release: Tania Micki to Succeed Long-time CFO Rudolf Eugster in Q1 2020 with effect from 2019 Annual Financial Statements". Männedorf. |
2019-08-30 |
| BioCity Group Ltd.. (8/29/19). "Press Release: BioCity Invests in Early-stage Precision Medicine Biotech Kinomica". Cheshire. |
2019-08-29 |
| Roche. (8/29/19). "Press Release: Roche Launches Ventana PD-L1 (SP142) Assay in CE Markets as First Companion Diagnostic to Identify Triple-negative Breast Cancer Patients Eligible for Treatment with Tecentriq". Basel. |
2019-08-29 |
| Adrenomed AG. (8/29/19). "Press Release: Adrenomed Supervisory Board Appoints Jens Schneider-Mergener as CEO and Jens Zimmermann, CMO, Joins the Executive Board". Hennigsdorf. |
2019-08-29 |
| Roche. (8/29/19). "Press Release: European Commission Approves Roche’s Tecentriq in Combination with Abraxane for People with PD-L1-positive, Metastatic Triple-negative Breast Cancer". Basel. |
2019-08-29 |
| Vivoryon Therapeutics AG. (8/29/19). "Press Release: Vivoryon Therapeutics Reports Financial Results for H1 2019 and Corporate Update". Halle (Saale). |
2019-08-29 |
| Galapagos N.V.. (8/28/19). "Press Release: Transparency Notification – Gilead Holds 22% of Galapagos Shares". Mechelen. |
2019-08-28 |
| Unibio International plc. (8/28/19). "Press Release: Unibio Completes USD 15 M (GBP 12.4 M) Financing Round". London & Copenhagen. |
2019-08-28 |
| Immatics Biotechnologies GmbH. (8/28/19). "Press Release: Immatics and Celgene Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies". Houston, TX & Tübingen. |
2019-08-28 |
| HiFiBio Therapeutics. (8/28/19). "Press Release: HiFiBio Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders". Cambridge, MA, Shanghai & Paris. |
2019-08-28 |
| Sanofi S.A.. (8/28/19). "Press Release: U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9". Paris & Tarrytown, NY. |
2019-08-28 |
| Ascendis Pharma A/S. (8/28/19). "Press Release: Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results". Copenhagen. |
2019-08-28 |
| IBB Beteiligungsgesellschaft mbH. (8/27/19). "Pressemitteilung: Berliner Startup Krankenhaus.de sammelt Seed-Runde ein". |
2019-08-27 |
| Abionyx Pharma S.A.. (8/27/19). "Press Release: Change of Name and Stock Symbol/Mnemonic of Abionyx Pharma Shares (formerly Cerenis Therapeutics) as of August 29, 2019". Toulouse & Lakeland, US. |
2019-08-27 |
| Nanovi A/S. (8/27/19). "Press Release: Nanovi Raises New Capital". Copenhagen. |
2019-08-27 |
| Adaptimmune Therapeutics plc. (8/27/19). "Press Release: Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products Expressing IL-7 and CCL19 as a Next-generation Treatment for Cancer Patients". Philadeliphia, PA & Oxfordshire. |
2019-08-27 |
| Vaccitech Ltd.. (8/27/19). "Press Release: Vaccitech Appoints Bill Enright as New Chief Executive Officer". Philadeliphia, PA & Oxfordshire. |
2019-08-27 |
| ADC Therapeutics S.A.. (8/26/19). "Press Release: ADC Therapeutics and Freenome Enter Biomarker Development Collaboration". Lausanne & South San Francisco, CA. |
2019-08-26 |
| Bruker Corporation. (8/26/19). "Press Release: Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data". Berlin. |
2019-08-26 |
| Bruker Corporation. (8/25/19). "Press Release: Bruker Introduces Next-Generation 80 MHz Benchtop FT-NMR System". Berlin. |
2019-08-25 |
| Galapagos N.V.. (8/23/19). "Press Release: Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration". Foster City, CA & Mechelen. |
2019-08-23 |
| GlaxoSmithKline plc. (8/23/19). "Press Release: GSK Announces Positive Headline Results from the Pivotal DREAMM-2 Study for Multiple MMyeloma". London. |
2019-08-23 |
| Idorsia Ltd.. (8/23/19). "Press Release: Clinical Data on Idorsia’s Pipeline Compounds Will Be Presented at the European Society of Cardiology Congress 2019". Allschwil. |
2019-08-23 |
| GlaxoSmithKline plc. (8/22/19). "Press Release: ViiV Healthcare Reports Positive Phase III Study Results of Investigational, Long-acting, Injectable HIV-treatment Regimen Administered every Two Months". London. |
2019-08-22 |
| AstraZeneca plc. (8/22/19). "Press Release: Roxadustat Approved in China for the Treatment of Anaemia in Non-dialysis-dependent Patients with Chronic Kidney Disease". |
2019-08-22 |
| AstraZeneca plc. (8/22/19). "Press Release: AstraZeneca Agrees to Buy US FDA Priority Review Voucher from Sobi". |
2019-08-22 |
| RhoVac AB. (8/22/19). "Press Release: RhoVac AB Has Been Granted 2.5 Million Euro from Horizon 2020". |
2019-08-22 |
| MDClone Ltd.. (8/22/19). "Press Release: MDClone, Developer of First Healthcare Synthetic Data Engine, Raises $26 Million". Beer-Sheva. |
2019-08-22 |
| Themis Bioscience GmbH. (8/22/19). "Press Release: Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates". Vienna. |
2019-08-22 |
| GlaxoSmithKline plc. (8/21/19). "Press Release: GSK Submits First Regulatory Application for Daprodustat in Japan for Patients with Renal Anaemia Due to Chronic Kidney Disease". London. |
2019-08-21 |
| Oncorus, Inc.. (8/21/19). "Press Release: Oncorus Announces $79.5 Million Series B Financing Co-Led by Cowen Healthcare Investments and Perceptive Advisors". Cambridge, MA. |
2019-08-21 |
| Rexgenero. (8/21/19). "Press Release: Atelerix Consortium Awarded £267,000 Innovate UK Grant for Collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies". London. |
2019-08-21 |
| AstraZeneca plc. (8/21/19). "Press Release: Update on the Phase III NEPTUNE Trial of Imfinzi plus Tremelimumab in Stage IV Non-small Cell Lung Cancer". |
2019-08-21 |
| PerkinElmer, Inc.. (8/21/19). "Press Release: PerkinElmer Announces Leadership Succession Plan". Waltham, MA. |
2019-08-21 |
| Cytosurge AG. (8/21/19). "Press Release: Cytosurge AG Announces Spin-off of Its 3D Printing Business Unit". Glattbrugg. |
2019-08-21 |
| AstraZeneca plc. (8/20/19). "Press Release: Farxiga Met Primary Endpoint in Landmark Phase III DAPA-HF Trial for the Treatment of Patients with Heart Failure". |
2019-08-20 |
| Medicines and Healthcare Products Regulatory Agency (MHRA). (8/20/19). "Press Release: Dr June Raine to Become Interim Chief Executive Officer". |
2019-08-20 |
| Uniqure N.V.. (8/20/19). "Press Release: Uniqure Announces Leadership Promotions and Executive Transition". Lexington, MA & Amsterdam. |
2019-08-20 |
| Bayer AG. (8/20/19). "Press Release: Bayer to Sell Its Animal Health Business Unit to Elanco for 7.6 Billion U.S. Dollars". Leverkusen. |
2019-08-20 |
| Eppendorf AG. (8/20/19). "Press Release: Eppendorf AG with Positive First Half-year 2019. Group Sales Grow by 12.8% Percent to €378.5 million". Hamburg. |
2019-08-20 |
| Alligator Bioscience AB. (8/20/19). "Press Release: Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.". Lund. |
2019-08-20 |
| Araris Biotech AG. (8/20/19). "Press Release: Araris Biotech AG Closes Seed Financing Round of CHF 2.5 Million". Zurich. |
2019-08-20 |
| Nabriva Therapeutics plc. (8/19/19). "Press Release: Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)". Dublin. |
2019-08-19 |
| Juvenescence Ltd.. (8/19/19). "Press Release: Juvenescence Closes $100 Million Series B Round, Plans Follow On and Incremental Investments in Longevity Drug Development". Tortola, British Virgin Islands. |
2019-08-19 |
| Amoéba S.A.. (8/19/19). "Press Release: Amoéba Informs that the EPA Cannot Grant the Registrations for the Use of Its Active Substance Willaertia magna C2c Maky in Cooling Towers". Lyon. |
2019-08-19 |
| Genentech, Inc.. (8/19/19). "Press Release: Retirement of Dr. Sandra Horning & Appointment of Dr. Levi Garraway to Chief Medical Officer, Roche and Genentech". South San Francisco, CA. |
2019-08-19 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo-2019.png){kind=logo}
1 2 3 ... 168 169 170 
Date![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
![Picture [iito] LSUS iitoLifeScience Transatlantic Life Sciences 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
